CSOP Bitcoin Futures Daily (-1x) Inverse Product
07376
Harvest Bitcoin Spot ETF
03439
ChinaAMC Bitcoin ETF
03042
CSOP Bitcoin Futures ETF
03066
Samsung Bitcoin Futures Active ETF
03135
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -26.75%-22.24B | ---- | 18.65%-17.55B | ---- | -164.22%-21.57B | ---- | 15.77%33.59B | ---- | 28.17%29.02B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 27.43%-284.16M | ---- | 55.97%-391.55M | ---- | 27.66%-889.25M | ---- | -33.05%-1.23B | ---- | -14.67%-923.87M |
Interest expense - adjustment | ---- | -2.59%6.42B | ---- | 10.91%6.59B | ---- | 156.69%5.94B | ---- | 121.59%2.31B | ---- | 15.19%1.04B |
Attributable subsidiary (profit) loss | ---- | 676.09%1.02B | ---- | -69.57%131.72M | ---- | 371.73%432.93M | ---- | -64.54%-159.32M | ---- | -141.47%-96.83M |
Impairment and provisions: | ---- | 343.64%6.09B | ---- | -95.77%1.37B | ---- | 6,589.19%32.48B | ---- | 137.02%485.57M | ---- | 218.33%204.86M |
-Impairment of property, plant and equipment (reversal) | ---- | --6.46M | ---- | ---- | ---- | --1.19B | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | 343.17%6.09B | ---- | -95.61%1.37B | ---- | 6,344.87%31.29B | ---- | 137.02%485.57M | ---- | 218.33%204.86M |
Revaluation surplus: | ---- | 948.62%5.92B | ---- | 34.85%564.17M | ---- | 272.95%418.38M | ---- | 89.83%-241.91M | ---- | -23.37%-2.38B |
-Fair value of investment properties (increase) | ---- | 830.93%5.88B | ---- | 4.96%631.45M | ---- | 251.33%601.61M | ---- | 82.98%-397.54M | ---- | -22.25%-2.34B |
-Derivative financial instruments fair value (increase) | ---- | 156.09%37.71M | ---- | -74.63%-67.22M | ---- | -156.48%-38.49M | ---- | 269.16%68.15M | ---- | -257.23%-40.29M |
-Other fair value changes | ---- | ---- | ---- | 99.96%-57K | ---- | -265.46%-144.75M | ---- | 3,106.22%87.48M | ---- | 54.17%-2.91M |
Asset sale loss (gain): | ---- | 219.89%3.45B | ---- | -780.85%-2.88B | ---- | 202.41%422.8M | ---- | -123.19%-412.85M | ---- | -246.47%-184.98M |
-Loss (gain) from sale of subsidiary company | ---- | 219.89%3.45B | ---- | -14,631.74%-2.88B | ---- | 159.55%19.81M | ---- | 19.17%-33.26M | ---- | 22.92%-41.15M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | 206.16%402.99M | ---- | -163.93%-379.59M | ---- | ---143.82M |
Depreciation and amortization: | ---- | -13.26%1.09B | ---- | 22.69%1.26B | ---- | 4.38%1.03B | ---- | 3.14%984.67M | ---- | 43.80%954.69M |
-Depreciation | ---- | -16.77%914.44M | ---- | 28.52%1.1B | ---- | 13.52%854.85M | ---- | 2.74%753.07M | ---- | 25.18%732.95M |
Exchange Loss (gain) | ---- | -79.38%1.84B | ---- | 491.11%8.92B | ---- | 48.15%-2.28B | ---- | -2,772.35%-4.4B | ---- | -24.01%164.65M |
Special items | ---- | -68.18%17.45M | ---- | -60.40%54.82M | ---- | 262.19%138.43M | ---- | -168.19%-85.35M | ---- | 9.55%125.17M |
Operating profit before the change of operating capital | ---- | 272.46%3.32B | ---- | -111.95%-1.93B | ---- | -47.75%16.12B | ---- | 10.46%30.85B | ---- | 26.64%27.92B |
Change of operating capital | ||||||||||
Developing property (increase)decrease | ---- | 5.88%34.38B | ---- | 74.91%32.47B | ---- | 185.28%18.57B | ---- | -47.01%-21.77B | ---- | 46.39%-14.81B |
Accounts receivable (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 489.66%6.07B |
Accounts payable increase (decrease) | ---- | 78.27%-2B | ---- | 57.60%-9.19B | ---- | -308.39%-21.66B | ---- | -46.77%10.39B | ---- | 54.31%19.53B |
prepayments (increase)decrease | ---- | -487.34%-7.98B | ---- | 699.57%2.06B | ---- | -117.84%-343.58M | ---- | --1.93B | ---- | ---- |
Special items for working capital changes | ---- | -45.23%-28.81B | ---- | -2,999.54%-19.83B | ---- | -57.51%684.07M | ---- | -73.74%1.61B | ---- | 1,335.80%6.13B |
Cash from business operations | -151.54%-1.27B | -130.05%-1.08B | -32.52%2.46B | -73.15%3.59B | -81.13%3.64B | -41.93%13.36B | 209.77%19.29B | -48.70%23.01B | -66.40%6.23B | 209.37%44.85B |
China income tax paid | 74.90%-474.85M | 4.43%-2.5B | 23.98%-1.89B | 71.87%-2.62B | 64.42%-2.49B | -10.69%-9.31B | -53.02%-7B | -11.14%-8.41B | 7.95%-4.57B | -25.21%-7.57B |
Interest received - operating | -31.88%66.65M | -27.43%284.16M | -39.59%97.85M | -55.97%391.55M | -71.34%161.96M | -27.66%889.25M | 0.81%565.1M | 33.05%1.23B | 16.85%560.55M | 17.52%923.87M |
Interest paid - operating | 71.30%-288.83M | 61.77%-2.17B | 68.09%-1.01B | 60.88%-5.69B | 27.76%-3.15B | -61.75%-14.54B | -4.86%-4.37B | -2.95%-8.99B | -3.03%-4.16B | -24.14%-8.73B |
Net cash from operations | -468.26%-1.96B | -26.45%-5.47B | 81.25%-345.34M | 54.90%-4.33B | -121.70%-1.84B | -240.20%-9.59B | 535.74%8.49B | -76.79%6.84B | -119.49%-1.95B | 1,233.99%29.48B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | -83.46%9.5M | 337.97%98.54M | --57.44M | -98.43%22.5M | ---- | 43.46%1.43B | 21.03%678.41M | -0.13%997.73M | --560.56M | 1,256.60%999M |
Loan receivable (increase) decrease | -57.69%214.11M | 114.12%864.34M | 115.96%506.01M | 82.94%-6.12B | 64.35%-3.17B | -213.18%-35.89B | -35,295.75%-8.89B | -142.11%-11.46B | 98.54%-25.13M | -583.70%-4.73B |
Sale of fixed assets | -89.59%64.13M | 274.11%694.57M | 1,164.83%615.86M | -9.10%185.66M | 148.89%48.69M | 438.53%204.23M | 137.27%19.56M | 595.85%37.92M | -48.57%8.25M | -71.89%5.45M |
Purchase of fixed assets | 11.39%-83.49M | 45.96%-438.12M | 52.09%-94.22M | 45.14%-810.69M | 73.80%-196.68M | 76.87%-1.48B | 63.14%-750.72M | -310.13%-6.39B | -78.74%-2.04B | 49.90%-1.56B |
Selling intangible assets | ---- | -91.24%48K | ---- | 55.68%548K | ---- | -83.71%352K | --1.79M | --2.16M | ---- | ---- |
Purchase of intangible assets | -704.58%-2.29M | -131.46%-54.89M | 97.92%-284K | 76.82%-23.71M | 52.30%-13.67M | 75.87%-102.29M | 86.29%-28.65M | -1,073.14%-423.96M | -222.80%-209.07M | 78.78%-36.14M |
Sale of subsidiaries | 172.09%185.05M | -103.94%-362.07M | -103.60%-256.7M | 193.74%9.19B | 2,453.92%7.12B | 348.98%3.13B | -34.67%278.94M | 388.22%696.97M | 187.97%426.95M | -16.84%142.76M |
Acquisition of subsidiaries | ---- | -121.12%-558.67M | ---- | 211.46%2.64B | 251.44%1.15B | -1,011.40%-2.37B | -130.02%-761.57M | 116.01%260.37M | 426.95%2.54B | -33,510.02%-1.63B |
Recovery of cash from investments | 222.23%285M | -36.18%758.27M | -89.27%88.45M | -9.48%1.19B | 358.28%824.28M | 372.69%1.31B | 169.22%179.86M | 36.07%277.7M | --66.81M | 206.63%204.09M |
Cash on investment | ---- | 99.66%-2M | ---- | 74.34%-596.71M | 99.85%-2.45M | 69.15%-2.33B | 51.20%-1.59B | 21.03%-7.54B | 46.76%-3.27B | -272.37%-9.54B |
Other items in the investment business | ---- | --49M | ---- | ---- | ---- | -8.95%264.7M | ---- | --290.73M | 150.10%290.73M | ---- |
Net cash from investment operations | -26.68%672.01M | -81.53%1.05B | -84.11%916.55M | 115.85%5.68B | 153.04%5.77B | -54.13%-35.83B | -559.24%-10.87B | -43.96%-23.25B | 83.89%-1.65B | -160.09%-16.15B |
Net cash before financing | -325.90%-1.29B | -426.58%-4.42B | -85.44%571.22M | 102.98%1.35B | 264.78%3.92B | -176.89%-45.42B | 33.80%-2.38B | -223.02%-16.4B | -1,402.87%-3.6B | 433.49%13.33B |
Cash flow from financing activities | ||||||||||
New borrowing | -58.23%2.07B | -66.84%8.29B | -47.34%4.97B | -81.05%24.99B | -78.41%9.43B | 96.80%131.89B | 21.16%43.67B | 23.78%67.01B | 24.36%36.04B | -25.88%54.14B |
Refund | 66.06%-2.98B | 69.29%-14.47B | 58.20%-8.79B | 31.68%-47.12B | 10.32%-21.03B | -15.18%-68.97B | 38.23%-23.45B | -28.61%-59.88B | -58.17%-37.96B | 15.42%-46.56B |
Issuing shares | ---- | ---- | ---- | ---- | ---- | -83.92%2.39B | ---- | --14.87B | --7.99B | ---- |
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -46.64%2.28B | --726M | 150.88%4.27B |
Dividends paid - financing | -50.62%-44.73M | -1,206.89%-162.85M | -655.32%-29.7M | 99.72%-12.46M | 99.29%-3.93M | 36.50%-4.42B | 51.18%-555.5M | -20.45%-6.95B | -84.91%-1.14B | -72.23%-5.77B |
Absorb investment income | -25.34%2.49M | ---- | -50.81%3.34M | -99.69%7.69M | -99.87%6.78M | -81.11%2.5B | -22.29%5.12B | 172.91%13.21B | 368.98%6.58B | -22.29%4.84B |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | -765.43%-1.55B | -960.84%-1.55B | 90.05%-179.1M | ---146.11M | 61.70%-1.8B | ---- | -100.05%-4.7B |
Other items of the financing business | -101.76%-27.95M | 211.48%3.98B | 177.03%1.59B | 88.57%-3.57B | 75.57%-2.07B | -859.97%-31.22B | -722.11%-8.46B | 69.71%-3.25B | 147.44%1.36B | -865.40%-10.74B |
Net cash from financing operations | 55.49%-1.02B | 91.08%-2.44B | 84.95%-2.29B | -185.56%-27.32B | -194.35%-15.24B | 26.20%31.93B | 19.45%16.16B | 640.58%25.3B | 376.16%13.52B | -124.49%-4.68B |
Effect of rate | -91.59%3.1M | -95.52%8.21M | -92.25%36.83M | -31.46%183.1M | 1,207.08%475.35M | 224.13%267.16M | -288.68%-42.94M | -1,484.88%-215.22M | 712.71%22.76M | -59.12%15.54M |
Net Cash | -34.20%-2.31B | 73.59%-6.86B | 84.78%-1.72B | -92.45%-25.96B | -182.17%-11.32B | -251.65%-13.49B | 38.74%13.77B | 2.80%8.9B | 281.67%9.93B | -42.74%8.65B |
Begining period cash | -31.08%15.19B | -53.92%22.03B | -53.92%22.03B | -21.66%47.81B | -21.66%47.81B | 16.58%61.04B | 16.58%61.04B | 19.84%52.36B | 19.84%52.36B | 53.09%43.69B |
Cash at the end | -36.71%12.88B | -31.08%15.19B | -44.96%20.35B | -53.92%22.03B | -50.55%36.97B | -21.66%47.81B | 20.00%74.77B | 16.58%61.04B | 34.60%62.31B | 19.84%52.36B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | -- | -- | -- | -- | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.